Atlantic Family Wealth’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$413K Buy
1,643
+269
+20% +$57.9K 0.26% 27
2026
Q1
$299K Buy
1,374
+34
+3% +$7.54K 0.22% 42
2025
Q4
$306K Sell
1,340
-399
-23% -$90.9K 0.23% 38
2025
Q3
$403K Buy
1,739
+139
+9% +$28.3K 0.31% 23
2025
Q2
$297K Buy
1,600
+144
+10% +$26.8K 0.26% 29
2025
Q1
$305K Buy
+1,456
New +$283K 0.28% 30

Other funds holding ABBV

Atlantic Family Wealth's ABBV Position: Q2 2026 in Review

Atlantic Family Wealth increased its AbbVie (ABBV) stake by 20% in Q2 2026, buying an estimated $57.9K and bringing the position to 1,643 shares worth $413K. The position accounts for 0.26% of the portfolio, ranked #27.

Atlantic Family Wealth first reported a position in ABBV in Q1 2025 and has held it in 6 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Atlantic Family Wealth held 1,643 shares of AbbVie worth $413K as of Q2 2026.
  • Atlantic Family Wealth bought 269 AbbVie shares in Q2 2026, an estimated $57.9K.
  • AbbVie made up 0.26% of Atlantic Family Wealth's portfolio in Q2 2026, its #27 holding.
  • Atlantic Family Wealth first reported a position in AbbVie in Q1 2025 and has held it in 6 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Atlantic Family Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.